NEA Partners 14, L.P.'s Net Worth

$167 Million

Who is NEA Partners 14, L.P.?

NEA Partners 14, L.P. has an estimated net worth of $167 Million. This is based on reported shares across multiple companies, which include Strongbridge Biopharma plc, INTERLEUKIN GENETICS INC, MULESOFT, INC, Oyster Point Pharma, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Galera Therapeutics, Inc., Tracon Pharmaceuticals, Inc., SYNLOGIC, INC., Cerecor Inc., IMARA Inc., Casper Sleep Inc., and ZeroFox Holdings, Inc..

SEC CIK

NEA Partners 14, L.P.'s CIK is 0001551531

Past Insider Trading and Trends

2018 was NEA Partners 14, L.P.'s most active year for acquiring shares with 30 total transactions. NEA Partners 14, L.P.'s most active month to acquire stocks was the month of February. 2022 was NEA Partners 14, L.P.'s most active year for disposing of shares, totalling 19 transactions. NEA Partners 14, L.P.'s most active month to dispose stocks was the month of December. 2017 saw NEA Partners 14, L.P. paying a total of $24,009,000.00 for 58,948,211 shares, this is the most they've acquired in one year. In 2017 NEA Partners 14, L.P. cashed out on 70,082,988 shares for a total of $66,073,750.64, their largest year based on trade value.